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Abstract
Corneal endothelial cell derived plasma membrane vesicles were used to investigate the presence of NaqrCly,
NaqrHCOy and NaqrKqr2Cly co-transporter activity in the plasma membranes of these cells. NaqrHq exchange was3
blocked by the presence of 1 mM amiloride in all determinations. The rate of accumulation of Naq in the presence of
chloride or bicarbonate was not significantly different from its accumulation in the presence of acetate, thiocyanate or
gluconate. The addition of Kq to Naq plus Cly did not stimulate Naq accumulation into the vesicles. The present work
provides no evidence for NaqrKqr2Cly, NaqrCly or NaqrHCOy co-transport in corneal endothelial cell plasma3
membrane vesicles. q 1997 Elsevier Science B.V.
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1. Introduction
Bicarbonate is actively transported by the corneal
endothelium from corneal stroma to aqueous humour
and in doing so regulates corneal hydration and con-
w x ysequently corneal transparency 1,2 . To move HCO3
across the endothelial cell requires metabolic energy
w x2,3 , which is thought to be harnessed by the basolat-
eral plasma membrane-bound NaqrKq-ATPase
w x q q2,4–6 because inhibition of Na rK -ATPase by
ouabain causes complete inhibition of the endothelial
w x qtransport processes 7,8 . The absence of a net Na
w xflux in the short-circuited preparation 9 and the
q q w xbaso-lateral location of the Na rK -ATPase 6 , has
) Corresponding author. Tel.: q44-1222-874374; fax: q44-
1222-874859.
led to the suggestion that Naq entry into the cell
across the basolateral membrane and down its elec-
trochemical gradient is by a mechanism which is
coupled to and drives the transendothelial HCOy3
w x yflux 10 . The various models that describe net HCO3
transport suggest a number of possible mechanisms
for coupling trans-membrane Naq flux and
transendothelial net HCOy flux. These include a3
direct coupling via a NaqrHCOy cotransporter3
w x11,12 , or an indirect coupling utilising a
NaqrKqr2Cly cotransporter further coupled to a
y y w xCl rHCO exchanger 10 . Other models suggest3
that an amiloride inhibitable NaqrHq exchanger lo-
cated on the baso-lateral membrane can contribute to
y w xHCO movement 13,14 , although this activity has3
been suggested not to contribute directly to the en-
w xdothelial osmotic pump 15 . To distinguish between
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the several coupling mechanisms it is necessary to
investigate the transporters present in the plasma
membranes of these cells.
One method that can be used to investigate trans-
porter activity in membranes is to use isolated plasma
membrane vesicles. Plasma membrane vesicles can
be made essentially free of cell organelles and can
provide a pure membrane sample with its associated
transporters. A further advantage is that the internal
and external compartments can be controlled. Their
use has been successful in determining transport ac-
tivity in a number of tissues other than corneal
w xendothelium 16–20 . In this study we used corneal
endothelial cell plasma membrane vesicles to investi-
gate the mechanisms of coupling between Naq and
HCOy. By controlling the external and internal com-3
partments of the vesicle we were able to monitor ion
movement, in particular Naq, across the membranes.
We studied the uptake process at 258C at which
temperature the corneal endothelium is still able, by
its transport capability, to maintain the transparency
w xof the cornea 21 . We could find no evidence for
NaqrKqr2Cly, NaqrCly, or NaqrHCOy co-trans-3
porters in isolated corneal endothelial cell plasma
membrane vesicles.
2. Materials and methods
2.1. Preparation of plasma membrane ˝esicles
Bovine eyes were obtained from a local abattoir
2–4 h post-mortem. The eyes were used immediately
or refrigerated at 48C for use within 24 h.
To isolate corneal endothelial cells a small incision
was made in the sclera, approximately 3 mm from the
limbus. This incision was extended around the globe
and the cornea with the scleral rim removed from the
rest of the eyeball. The cornea was washed in 20 ml
of 250 mM sorbitol to remove traces of iris pigment
and unwanted tissue. One experimental batch com-
prised 16 ox eyes. The endothelial cells were re-
moved by scraping and were transferred into 2 ml of
250 mM sorbitol. The cell suspension was carefully
transferred to a 1 ml Potter-Elvehjem homogenizer
and homogenised with four strokes of the plunger.
This suspension was centrifuged using self-forming
Percoll gradients under isopycnic centrifugation for
30 min at 48C at 29,000 rpm 80,000=g ; 60,000max
. w x=g 5 . Following centrifugation three distinctavg
bands were visible in the Percoll gradient, previously
identified as: band 1, the nuclear enriched fraction;
band 2, the plasma membrane enriched fraction and
w xband 3, the mitochondrial enriched fraction 5 . The
plasma membrane fraction was removed and trans-
ferred into a clean centrifuge tube. The plasma mem-
brane fraction was then centrifuged at 35,000 rpm
 .118,000=g ; 90,000=g for 1 h to sedimentmax avg
out the membranes from the Percoll. After removal of
Percoll, 300 ml of the final pellet containing the
membranes was resuspended in 300 ml of a buffered
sorbitol solution A with a final composition of in
.mM ; 250, sorbitol; 0.2, CaSO ; 10, MgSO ; 1,4 4
amiloride; 10, Hepes; 10, Trizma base; at pH 7.5.
This solution A provided the intravesicular compart-
ment at the start of every experiment carried out in
this series. Plasma membrane vesicles were formed
by passing the membrane suspension four times
through a 19G hypodermic needle.
2.2. Naq uptake into the ˝esicles
22Naq uptake into the vesicle was measured using
w xa rapid filtration technique 20 . To initiate the trans-
port reaction, 10 ml of vesicle suspension made to a
y1.concentration of 0.4 mg protein ml was shaken
together with 10 ml of bathing solution containing
.radiolabelled substrate . Final external solution con-
centrations depended upon the particular membrane
proteins being investigated but were based upon an
iso-osmotic substitution of the intra-vesicular medium
 .solution A above in which salts replaced a fraction
of the sorbitol. The vesicle suspension and the bathing
solution were mixed in a waterbath at 258C. The
bathing solution always included at least 6 kBq of
22Na in order to monitor Na uptake rates into the
vesicle. The reaction was terminated after 15 s by the
 .addition of 3 ml of ice-cold ‘stop’ solution A above .
The diluted ice-cold suspension was quickly filtered
through a pre-wetted membrane filter HAWP 02500,
.0.45 m pore size attached to a Millipore vacuum
pump assembly under light suction. The filters were
then washed with 3 ml of stop solution, removed and
 .placed in 10 ml of scintillation fluid Ecoscint . Each
determination was performed five times and the ac-
tivities were measured in a liquid scintillation counter
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and were used to calculate the rate of Naq uptake
during the 15 s exposure period. All data were cor-
rected for non-specific trapping of 22Na by the mem-
branes and filters. To do this, uptake at ‘zero time’,
which is that measured when the vesicle and stop
solutions were added simultaneously, was subtracted
from the uptake after 15 s. Vesicle protein was
measured using Coomassie blue protein assay reagent,
with bovine serum albumin as standard.
In control experiments it was established that
22Naq uptake was, within the limits of experimental
error, linear for at least 15 s for the entire range of
experimental conditions considered in this paper
 .Lane, Wigham and Hodson, unpublished data .
Vesicle integrity for each experimental procedure
was checked by measurement of radiolabelled L-
alanine uptake into corneal endothelial cell plasma
membrane vesicles, in the presence of Naq or Kq
w xcontaining solutions 22 .
2.3. Reagents and materials
Percoll was obtained from Pharmacia LKB, Upp-
sala, Sweden; membrane filters from Millipore, UK;
22NaCl from Amersham, UK; 22Na acetate from NEN
Dupont, USA; Ecoscint from National Diagnostics,
USA. All other reagents were obtained from Sigma,
Poole, UK.
3. Results
3.1. Viability
The ionic dependence of L-alanine accumulation
was used to check the viability of the corneal en-
dothelial cell plasma membrane vesicles before and
after each experimental procedure. The ratio of up-
take in Naq compared to Kq solution after 15 s
 .incubation was 2.4"0.2 mean"S.D. .
3.2. Naq uptake in the presence of an inward Cl y
gradient
To determine the presence of NaqrCly cotrans-
porter activity, 22Naq uptake was measured in the
presence of an inward NaCl gradient which as a
control was substituted by an inward Na acetate
Fig. 1. The linear uptake rates of Naq into corneal endothelial
plasma membrane vesicles under gradients of 1 mM NaCl, 1 mM
Na acetate, 125 mM NaCl and 125 mM Na acetate during 15 s
incubations. The ordinate is logarithmic.
gradient. A number of solution concentrations were
tested but the chief results are reported for 1 mM
NaCl and Na acetate and for 125 mM NaCl and Na
 .acetate which are shown in Fig. 1. In no case ns5
was there any significant difference in the uptake:
there was no apparent NaqrCly co-transport activity
in corneal endothelium plasma membranes under the
conditions tested here. It was of interest to note that
the basal Naq uptake exhibited some form of satura-
w qxtion because when the Na in the bathing medium
increased by =125, the uptake increased only by
 qabout =26 from 2.3 " 0.1 nmol Na rmg
proteinr15 s up to 62"6 nmol Naqrmg proteinr15
.s .
3.3. Naq uptake in the presence of an inward HCOy3
gradient
To look for the presence of NaqrHCOy cotrans-3
porter activity, 25 mM KHCO was added to the3
external solution in order to produce an inwardly
directed HCOy gradient. NaCl was added to the3
external solution in amounts of 0.2, 1 or 40 mM 0.2
mM was used to check previously published data
w x23 ; 1 mM was used because in preliminary experi-
ments it was found to give the best signal to noise
ratio; 40 mM was used because that it is reported as
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the lowest physiological concentration of sodium
w x. ywhich will support the endothelial pump 1 . HCO3
independent 22Naq uptake was determined by substi-
tuting KHCO with 25 mM Kq thiocyanate or 253
mM Kq gluconate in the external solutions. 22Naq
had a final activity of 0.0185 MBq in each 10 ml of
bathing solution. All external solutions had appropri-
ate reductions in their sorbitol in order to maintain
isotonicity. The combined data of all 9 determina-
tions, which were each averaged from five determina-
tions on at least four separate samples is shown in
Fig. 2. There was no significant difference between
the rate of sodium accumulation in the vesicles in the
presence or absence of bicarbonate over the condi-
tions we tested.
3.4. Naq transport in the presence of inward K q
and Cl y gradients
To check for the presence of NaqrKqr2Cly co-
transporter activity in the membranes of the vesicles,
1 or 40 mM NaCl was added to the bathing solutions
Fig. 2. The linear uptake rates of Naq into corneal endothelial
 .plasma membrane vesicles under gradients of left three 0.2 mM
Naq plus 25 mM bicarbonate, gluconate and thiocyanate, respec-
 . qtively; middle three 1 mM Na plus 25 mM bicarbonate,
 .gluconate and thiocyanate, respectively and right three 40 mM
Naq plus 25 mM bicarbonate, gluconate and thiocyanate, respec-
tively. The ordinate is logarithmic.
Fig. 3. The linear uptake rates of Naq into corneal endothelial
 .plasma membrane vesicles under gradients of left three 1 mM
 .NaCl plus 0, 1 and 40 mM KCl, respectively and right three 40
mM NaCl plus 0, 1 and 40 mM KCl, respectively. The ordinate
is logarithmic.
together with 0, 1 or 40 mM KCl with appropriate
reductions in the sorbitol concentrations in order to
maintain iso-osmolarity. If the NaqrKqr2Cly co-
transporter is present in the corneal endothelial cell
membrane vesicles then the presence of Kq should
lead to a significant increase in uptake of 22Naq. The
rate of accumulation of 22Naq in 40 mM Na was
23.8"2.0 nmol Naq mgy1 protein 15 sy1 in the
absence of Kq, 25.7"2.8 nmol Naq mgy1 protein
15 sy1 in the presence of 1 mM Kq and 24.6"2.6
nmol Naq mgy1 protein 15 sy1 in the presence of 40
mM Kq. None of these results were significantly
different. Similarities were also found for 1 mM
 .NaCl Fig. 3 indicating that we found no evidence
for the presence of NaqrKqr2Cly activity in corneal
endothelial plasma membrane under the conditions
tested here.
4. Discussion
The integrity of the corneal endothelial plasma
membrane vesicles which we prepared was investi-
gated by looking for Naq dependent L-alanine up-
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take. The significantly higher uptake of L-alanine in
the presence of a Naq compared to Kq inward
gradient indicated that a constant proportion of the
vesicles possess their normal orientation and that
irregular osmotic disruption of the vesicles did not
 .occur. The consistency of the uptake ratio 2.4 in all
the experimental procedures we investigated indi-
cated that comparison between addition and deletion
of various salts to the bathing medium seemed not to
affect the transport capabilities of the vesicles and
was probably justified. The addition of amiloride has
been shown previously to reduce the uptake of
22N 22Naq into corneal endothelial membrane vesi-
w xcles via NHE 23 and as we were searching for
sodium coupling mechanisms additional to NHE, this
transport mechanism was routinely blocked in this
series of experiments.
The NaqrKqr2Cly cotransporter has been shown
to be present in many cell types studied, including
w x w xepithelial 16,24 and nonepithelial cells 25,26 . The
criteria used to describe its presence include inhibi-
tion by loop diuretics, such as furosemide and
bumetanide, and, more rigorously, by a demonstra-
tion that the transport of any of the component ions
w xrequires the presence of the others. Diecke et al 27
showed that in Naq free and Cly free solutions,
bumetanide sensitive Kq uptake was abolished in
cultured bovine corneal endothelial cells. Also, Hod-
w xson et al 10 reported the possibility of a
NaqrKqr2Cly cotransporter coupled to a
ClyrHCOy exchanger to generate entry of bicarbon-3
ate into corneal endothelium. This conclusion was
drawn from experiments where the Naq accumula-
tion rate into corneal endothelial plasma membrane
vesicles was reduced in the presence of the co-trans-
w xporter inhibitor furosemide 10,23 . However, Fig. 3
shows that 22Naq uptake into corneal endothelial cell
membrane vesicles was independent of a variety of
Kq and Cly gradients. The NaqrKqr2Cly co-trans-
porter appears not to be working in the corneal
plasma membrane vesicles used here which suggests,
in spite of furosemide sensitivity of the transport
characteristics, that it may not present in corneal
endothelial cells. This is consistent with other studies
which showed evidence against the existence of
NaqrKqr2Cly transport in corneal endothelium
w x28,29 . Furosemide is reported to be the least spe-
cific NaqrKqr2Cly cotransporter inhibitor of the
w xloop diuretics 30 . Perhaps the furosemide effect
w xseen in the studies reported by Hodson et al 10 were
due to inhibition of Naq entry into the vesicles via
routes other than the NaqrKqr2Cly cotransporter.
The results shown in Fig. 1, indicate that there is
little or no NaqrCly cotransporter activity in the
corneal endothelial membrane vesicles. Although this
laboratory has already reported the absence of
NaqrHCOy cotransporter activity in the corneal en-3
w xdothelial membrane vesicles 23 it was considered to
be useful to repeat these experiments using exactly
the same experimental protocol as in this series. As
reported previously 22Naq uptake into the corneal
endothelial membrane vesicles was found to be inde-
 .pendent of the nature of the anion Fig. 3 , which is
inconsistent with the proposed model of NaqrHCOy3
cotransport in corneal endothelial cells suggested by
w xother workers 11,12,28,31 .
The present work provides no evidence for
NaqrKqr2Cly, NaqrCly or NaqrHCOy cotrans-3
port in corneal endothelial cell plasma membrane
vesicles. The nature of the coupling mechanism be-
tween HCOy and Naq, which must exist in corneal3
endothelial cells is still unresolved.
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